Literature DB >> 2470173

Molecular genetic approaches to Alzheimer's disease.

R E Tanzi, P H St George-Hyslop, J F Gusella.   

Abstract

Alzheimer's disease (AD) has emerged in the past decade as a major public health problem. Epidemiological and neuropathological studies have revealed AD to be a very frequent disease associated with aging. Already the fourth leading cause of death in the USA and consuming a major component of health care costs, AD will take on even greater importance with the continuous growth of the elderly population. A concerted effort has been made in recent years to attack AD using an arsenal of powerful molecular biological techniques, concentrating on two areas: the characterization of proteins implicated in the pathogenesis of AD and of the genes that encode them; and the use of genetic linkage to approach the primary defect in a familial form of AD (FAD). This review attempts to summarize and interpret the recent molecular, genetic and biochemical findings concerning the pathogenesis of AD.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2470173     DOI: 10.1016/0166-2236(89)90055-6

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  11 in total

1.  Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease.

Authors:  H V Vinters; G S Nishimura; D L Secor; W M Pardridge
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

2.  Interleukin-1 stimulates the beta-amyloid precursor protein promoter.

Authors:  R J Donnelly; A J Friedhoff; B Beer; A J Blume; M P Vitek
Journal:  Cell Mol Neurobiol       Date:  1990-12       Impact factor: 5.046

Review 3.  Neurology.

Authors:  A N Gale; J M Gibbs; A H Schapira; P K Thomas
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401

4.  Phosphorylation of amyloid-β peptide at serine 8 attenuates its clearance via insulin-degrading and angiotensin-converting enzymes.

Authors:  Sathish Kumar; Sandesh Singh; Désirée Hinze; Michaele Josten; Hans-Georg Sahl; Martin Siepmann; Jochen Walter
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

5.  Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death.

Authors:  M S Shearman; C I Ragan; L L Iversen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

6.  Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide.

Authors:  R V Ward; K H Jennings; R Jepras; W Neville; D E Owen; J Hawkins; G Christie; J B Davis; A George; E H Karran; D R Howlett
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

7.  Immunocytochemical distribution of S-100 protein in patients with Down's syndrome.

Authors:  F Michetti; L M Larocca; A Rinelli; L Lauriola
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

8.  Mouse model of neurodegeneration: atrophy of basal forebrain cholinergic neurons in trisomy 16 transplants.

Authors:  D M Holtzman; Y W Li; S J DeArmond; M P McKinley; F H Gage; C J Epstein; W C Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

9.  Dysregulation of gene expression in mouse trisomy 16, an animal model of Down syndrome.

Authors:  D M Holtzman; R M Bayney; Y W Li; H Khosrovi; C N Berger; C J Epstein; W C Mobley
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

Review 10.  Novel Balance Mechanism Participates in Stem Cell Therapy to Alleviate Neuropathology and Cognitive Impairment in Animal Models with Alzheimer's Disease.

Authors:  Chuan Qin; Yongning Li; Kewei Wang
Journal:  Cells       Date:  2021-10-15       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.